Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Malignant Digestive System Neoplasm”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00862680
What this trial is testing

4D PET/CT in Diagnosing Participants With Lung and Colorectal Cancer With Liver and Lung Metastasis

Who this might be right for
Metastatic Malignant Neoplasm in the LiverMetastatic Malignant Neoplasm in the LungStage IV Colorectal Cancer AJCC v8+6 more
M.D. Anderson Cancer Center 75
Early research (Phase 1)Ended earlyNCT04873895
What this trial is testing

TACE Plus Axitinib and Hydroxychlorquine for Liver-Dominant Metastatic Colorectal Cancer (CRC)

Who this might be right for
Colorectal Neoplasms Malignant
Abramson Cancer Center at Penn Medicine 5
Testing effectiveness (Phase 2)UnknownNCT04777162
What this trial is testing

Tislelizumab Plus Anlotinib for Immunotherapy Resistant Gastrointestinal Cancer

Who this might be right for
Gastric CancerColo-rectal Cancer
Peking University 40
Testing effectiveness (Phase 2)Ended earlyNCT04424641
What this trial is testing

A Study on the Safety of GEN1044 (DuoBody®-CD3x5T4) in Patients With Malignant Solid Tumors

Who this might be right for
Locally Advanced or Metastatic Solid Tumor(s)Prostate CancerEsophageal Cancer+5 more
Genmab 48
Not applicableLooking for participantsNCT03978078
What this trial is testing

A Clinicobiological Database in Metastatic Digestive Cancers

Who this might be right for
Digestive System Neoplasm
Institut du Cancer de Montpellier - Val d'Aurelle 200
Not applicableEnded earlyNCT03889093
What this trial is testing

Radioembolization of Primary and Secondary Liver Malignancies and The Effect On The Immune System

Who this might be right for
Hepatocellular CarcinomaSecondary Malignant Neoplasm of Liver
University of Minnesota 14
Testing effectiveness (Phase 2)Ended earlyNCT03480152
What this trial is testing

Messenger RNA (mRNA)-Based, Personalized Cancer Vaccine Against Neoantigens Expressed by the Autologous Cancer

Who this might be right for
MelanomaColon CancerGastrointestinal Cancer+2 more
National Cancer Institute (NCI) 5
Not applicableWithdrawnNCT04985357
What this trial is testing

Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to Drugs

Who this might be right for
Stage III Breast CancerStage IV Breast CancerStage III Lung Cancer+35 more
Travera Inc
Testing effectiveness (Phase 2)UnknownNCT02779608
What this trial is testing

The Study of Intraperitoneal Docetaxel Plus S-1 for Malignant Ascites

Who this might be right for
Stomach NeoplasmsPeritoneal Metastasis
Fudan University 50
Early research (Phase 1)Looking for participantsNCT06500052
What this trial is testing

BL-M17D1 in Patients With Locally Advanced or Metastatic HER2 Positive/Lower Expression Gastrointestinal Cancer and Other Solid Tumors

Who this might be right for
Esophageal CancerGastric CancerPancreatic Cancer+2 more
Sichuan Baili Pharmaceutical Co., Ltd. 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT05669482
What this trial is testing

Study of Avutometinib (VS-6766) +Defactinib With Gemcitabine and Nab-paclitaxel in Patients With Pancreatic Cancer

Who this might be right for
KRAS Activating MutationMetastatic CancerPancreas Cancer+2 more
Verastem, Inc. 40
Not applicableEnded earlyNCT00904514
What this trial is testing

Study of Previously Collected and Stored Tissue Samples From Patients Previously Enrolled in a Completed National Cancer Institute Clinical Trial

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 241
Testing effectiveness (Phase 2)Looking for participantsNCT04273061
What this trial is testing

Investigating the Effects of Atezolizumab in People Whose Tumour DNA or RNA Indicates Possible Sensitivity

Who this might be right for
Breast CancerLung CancerGastrointestinal Cancer+6 more
British Columbia Cancer Agency 50
Not applicableUnknownNCT05138094
What this trial is testing

LIVACOR Trial: Minimally Invasive LIVer And Simultaneous COlorectal Resection

Who this might be right for
Colorectal Neoplasms MalignantNeoplasm Metastasis
Fondazione Poliambulanza Istituto Ospedaliero 82
Early research (Phase 1)Study completedNCT00004604
What this trial is testing

Biological Therapy in Treating Patients With Metastatic Cancer

Who this might be right for
Breast CancerColorectal CancerExtrahepatic Bile Duct Cancer+9 more
Duke University 24
Early research (Phase 1)WithdrawnNCT02915172
What this trial is testing

Lenvatinib and Capecitabine in Patients With Advanced Malignancies

Who this might be right for
Advanced CancerMalignant Neoplasm of BreastMalignant Neoplasms of Bone and Articular Cartilage+11 more
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Ended earlyNCT04387071
What this trial is testing

CMP-001 and INCAGN01949 for Patients With Stage IV Pancreatic Cancer and Other Cancers Except Melanoma

Who this might be right for
Locally Advanced Malignant Solid NeoplasmMetastatic Pancreatic AdenocarcinomaStage IV Pancreatic Cancer AJCC v8+1 more
University of Southern California 2
Testing effectiveness (Phase 2)Looking for participantsNCT07149090
What this trial is testing

Lenvatinib in Combination With Nivolumab Plus Chemotherapy in Metastatic Gastric Cancer Patients With Malignant Ascites

Who this might be right for
STOMACH NEOPLASMGastric CancerGastric Cancer Adenocarcinoma Metastatic
Asan Medical Center 61
Not applicableStudy completedNCT00248547
What this trial is testing

Aprepitant in Preventing Nausea and Vomiting in Patients Who Are Undergoing a Stem Cell Transplant

Who this might be right for
Cancer
OHSU Knight Cancer Institute 40
Early research (Phase 1)Study completedNCT04430842
What this trial is testing

Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S

Who this might be right for
AstrocytomaBrain CancerBrain Metastases+20 more
Quadriga Biosciences, Inc. 15
Next Page